The Experts in Animal Health

***********************************
Brakke Consulting’s
Animal Health News & Notes for January 24, 2025
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA
************************************

IN THE NEWS:
Brakke Consulting News
Cancer in Dogs and Cats report – preorder now
Brakke Consulting and Rehavior -VMX Seminar
Brakke Consulting 2025 Industry Overview

Earnings News
Virbac

Other News
Animine
AP
Bionet America
Bond Vet
Cascade Specialty Pharmacy
Cranswick
Elanco (Credelio Quattro)
Elanco (Senior Dog Veterinary Society)
Feedworks USA
Fi
Harrison’s Bird Foods
IDEXX
IndeVets
JSR Genetics
Lupa
Neogen
Next In Line
Parnell
Petvisor
Revelation Animal Health
Senior Dog Veterinary Society
Supreme Petfoods
Talkatoo
TARGAN
VetRec

*****************************************
Brakke Consulting
2025 Cancer in Dogs and Cats report – coming in March
Pre-order by February 28

Did you know that cancer is the #1 cause of death in adult dogs?  It’s also a leading health concern of dog owners.  So how is cancer addressed by the veterinary profession, and what kind of market is there for veterinary cancer therapies?

Brakke Consulting’s new 2025 Cancer in Dogs and Cats report includes information on the incidence, diagnosis, and treatment of the common veterinary cancers.  It covers currently approved veterinary therapies and those in development, as well as estimates of the numbers of pets treated.

The study includes a survey of 300 general veterinary practitioners about incidence of cancer and frequency of treatment; as well as a survey of 1,000 pet owners to determine what they are willing to pay to treat a pet with cancer.

The report is available for pre-order for $7,995 until February 28, and $8,500 thereafter. The report will be published in March. For more information, please contact Dr. Lynn Fondon at info@brakkeconsulting.com .

www.BrakkeConsulting.com

*********************************************
EARNINGS NEWS RELEASES

  • Virbac reported results for the full year 2024. Revenue reached EUR 1,398 million ($1,438 million), an increase of 12% compared to 2023 (+13.6% at constant exchange rates); organic growth was 7.5%. North American revenues were EUR 182 million ($187 million), an increase of 10%. (globenewswire)

*********************************************
Brakke Consulting
Elevate Your Business with Behavioral Science

Animal health companies and veterinary practices share a common challenge: missed opportunities for growth due to ineffective communication strategies. Brakke Consulting and Rehavior are proud to announce a strategic partnership aimed at revolutionizing how these businesses interact with their clients and customers.

Join us at VMX for an insightful seminar titled “Revolutionize Your Business with Behavioral Science.” This session will explore how integrating behavioral science with evidence-based research can significantly enhance client and customer engagement.

Key Takeaways:

  • Practical, personalized strategies to increase product sales and compliance.
  • Methods to improve pet health outcomes and profitability.
  • Insights into tailored messaging based on behavioral data, enhancing communication without additional training for your staff.

Don’t miss this opportunity to learn cutting-edge techniques that could transform your business operations. Attend our free one-hour seminar on Monday, January 27, 2025, at 11:00 AM in the Florida Ballroom BC – Convention Level

To register, click here.

www.BrakkeConsulting.com

**************************************
COMPANY NEWS RELEASES

  • Elanco Animal Health Incorporated announced the launch of Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) for dogs. The product is now available for veterinarians to order. (company press release)
  • The Senior Dog Veterinary Society announced a strategic alliance with Elanco Animal Health to offer veterinary professionals continued educational events and resources centered around caring for senior and geriatric dogs. (association press release)
  • IDEXX Laboratories, Inc. announced the launch of IDEXX Cancer Dx, a diagnostic panel for early detection of lymphoma in dogs. Early data shows IDEXX Cancer Dx testing can detect lymphoma before clinical signs are present. Panel expansion is planned over the next three years to cover the majority of canine cancer cases. (company press release)
  • Neogen announced the launch of its Igenity BCHF, a genomic test designed to assess a cow’s genetic predisposition to heart failure. Neogen also announced the launch of the Neogen Molecular Detection Assay 2 – Quantitative Salmonella. (Feedstuffs, Vet Advantage)
  • Parnell announced the launch of the Foundations of Anesthesia and Sedation Veterinary Certificate program, a comprehensive educational platform designed to help elevate anesthesia competency in veterinary practices nationwide. This program, which is composed of ten RACE-approved continuing education credits, is provided exclusively to clinics purchasing qualifying Parnell-manufactured products. (yahoo.com)
  • Bionet America, Inc. announced the launch of the new Super Air Smart Intensive Care Unit (ICU), providing a spacious, comfortable, and high-tech environment optimized for critical care, oxygen therapy, and more. (company press release)
  • Supreme Petfoods has launched a new range of Science Selective Care supplements, specifically formulated to support the health of rabbits, guinea pigs and chinchillas. These supplements offer targeted support for digestive, urinary and skin health while also contributing to overall wellbeing and quality of life for small herbivores. (company press release)
  • Animine announced it has partnered with Feedworks USA to expand its presence in the U.S. animal nutrition market. This collaboration is set to deliver mineral products designed to improve the health and performance of livestock, including swine, poultry, and dairy animals. (com)
  • Harrison’s Bird Foods announced that their Handbook for a Healthier Bird, a trusted resource for bird care, is now available in six languages. (company press release)
  • Fi announced the launch of a new range of dog supplements to the global market: Fi 8-in-1 Formula, Fi Hip & Joint, Fi Calming and Fi Skin & Coat. All the supplements in this range (bar the 8-in-1 formula) have received a National Animal Supplement Council (NASC) Quality Seal. (com)
  • Revelation Pharma, a national network of compounding pharmacies, announced its new animal-focused division, Revelation Animal Health. Separately, Revelation announced its acquisition of Washington-based Cascade Specialty Pharmacy. Cascade Specialty Pharmacy brings a robust legacy of excellence in ENT and Animal Health compounding. Financial terms were not disclosed. (com, Yahoo finance)
  • Talkatoo announced the launch of its call summary feature. This innovative tool allows users to make calls directly through the Talkatoo app while displaying their clinic’s caller ID. The tool records, transcribes, and summarizes every call, instantly delivering an AI-generated summary, transcript, and audio recording to the user’s note inbox. (company press release)
  • AP introduced its all-new Agri-Alert alarm technology, offering hog producers enhanced monitoring capabilities with cutting-edge features to ensure optimal barn conditions and animal health. (com)
  • IndeVets announced its expansion into California, marking the company’s 33rd state nationwide. (company press release)
  • Petvisor announced the launch of Petvisor Hub, a centralized platform designed to address the unique challenges of enterprise veterinary groups. Petvisor Hub unites communications (PetDesk), direct booking (formerly Vetstoria), phones (formerly Kontak), and web marketing data (formerly WhiskerCloud) to deliver the insights veterinary groups need to streamline workflows and drive efficiency across enterprise hospital portfolios. (prnewswire)
  • Next In Line announced the launch of Datahub, a platform designed to transform data management and operational efficiency for veterinary practices and technology partners across the veterinary industry. (com)
  • VetRec, a provider of AI-driven technology for veterinarians, announced a new partnership with Bond Vet. (yahoo.com)
  • POLAND TARGAN announced it has signed a contract for its WingScan automated feather-sexing system with Polish poultry producer IKO. The system is said to offer a throughput of 40,000 to 160,000 chicks per hour with up to 98% accuracy. (Vet Advantage)
  • UK Cranswick announced it has acquired JSR Genetics, one of the UK’s leading pig genetics companies and the exclusive distributor for Netherlands-based Topigs Norsvin’s genetics in the UK. JSR Genetics will remain as a separate entity, rather than being integrated into other parts of the Cranswick business. Financial terms were not disclosed. (Pig World)
  • UK Lupa, a London-based AI-native veterinary practice management platform, has closed $4 million in seed funding. Lupa will use the new funding to accelerate product development and commercial expansion. It wants to become an all-in-one ecosystem connecting veterinary practices with pet owners. (com)

*********************************************
ANIMAL HEALTH STOCK PRICE TRACKER

***********************************
ANIMAL HEALTH NEWS

  • SCOTLAND Research – led by the MRC-University of Glasgow Centre for Virus Research, in collaboration with an international team of scientists – has shown that horses have been infected with H5N1 avian influenza in Asia and that infections have been occurring in horses undetected. The results are published in the journal Emerging Infectious Diseases. (Vet Advantage – Paulick report)
  • US – AVIAN INFLUENZA The FDA has determined that it is necessary for manufacturers of cat and dog foods who are covered by the FDA Food Safety Modernization Act Preventive Controls for Animal Food (PCAF) rule and using uncooked or unpasteurized materials derived from poultry or cattle (e.g., uncooked meat, unpasteurized milk or unpasteurized eggs) to reanalyze their food safety plans to include Highly Pathogenic Avian Influenza virus (specifically H5N1) as a known or reasonably foreseeable hazard. The reanalysis is necessary to respond to the recent domestic cat illnesses and deaths from H5N1 and to scientific data indicating that cats and dogs have become ill from consuming H5N1 virus. (FDA)
  • US – ANIMAL FEED REGULATION The Association of American Feed Control Officials (AAFCO) membership voted on a new regulatory pathway for animal food ingredients, approving Kansas State University Olathe Innovation Campus’s proposal. Through the pathway, the university will provide scientific review for new ingredient submissions for use in pet food and animal feed. The new pathway replaces AAFCO’s Memorandum of Understanding with the US FDA, which expired in October 2024. (Petfood Processing)

************************************
Brakke Consulting
Brakke Consulting 2025 Industry Overview

Presented at VMX: Monday, January 27th, 2-4 pm, Hyatt Regency, Plaza Intl Ballroom G
Presented at WVC: Monday, March 3rd , 2-4 pm, Four Seasons Ballroom 4

How did the top animal health companies perform in 2024?  What critical issues and new products will impact industry performance in 2025?  Answers to these questions and more will be covered at Brakke Consulting’s annual Industry Overview at the VMX and WVC conferences next year.  Key topics and presenters include:

  • Industry and Top Global Company 2024 Performance, presented by Bob Jones
  • Pets and Vets – What Happened in 2024, presented by John Volk
  • Parasiticides in Pets – Back to the Future, presented by Darrell Klug
  • Regenerative Medicine ─ Future Game-Changing Therapies, presented by Mike McGinley

Also, again at both events, you will be able to hear directly from a panel of top leaders in the animal health industry.  Moderated by Paul Casady, the topic for the panel will be “Opportunities and Challenges in 2025.” The panelists for VMX are Jeff Simmons, President and CEO of Elanco Animal Health, and Jay H. Price, DVM, CEO of Southern Veterinary Partners.

This information-packed 2-hour session will be especially valuable for executive leadership, sales and marketing, strategy, and finance managers and for decision makers in the animal health industry.

VMX – SOLD OUT!
Click here to register for WVC

You can also email Amanda McDavid or call at 336-396-3916. Registration cost is $399; there are discounts for multiple attendees from the same company.  We look forward to seeing you there!

www.BrakkeConsulting.com

************************************
BRAKKE CONSULTING VIEWPOINT
Last week, the annual JP Morgan annual healthcare conference concluded.  Many of the top human and animal health companies presented their future visions to the investing community.  Zoetis and Elanco were front and center and Merck mentioned its animal health business as part of its human health presentation.

I took a few minutes to look at the pipeline focus and products highlighted in these presentations.  The pipelines are heavily concentrated on the companion animal segment.  Therapeutic areas of focus in the pipelines include osteoarthritis/pain, renal disease, oncology, cardiology, dermatology and the next generation of parasiticides.  Many of the pipeline products are monoclonal antibodies, injectable products and focused on long-acting formulations.  What does this mean for the livestock segment?  Maybe it’s just a lack of visibility into livestock pipeline products but it certainly seems that the R&D focus is on the segment of the market providing the highest growth rates.

It will be interesting to see how the overall market evolves with the next wave of innovation.  These new therapies that are primarily delivered via injections will drive patients back to the veterinary clinic.  Will there be a bifurcation of the prescription market with Chewy/Amazon/PetMeds focusing on oral prescription and OTC products and veterinarians focusing on injectables and vaccines?

We will talk about innovation at the Brakke Consulting annual Industry Overview presentation at both VMX and WVC – hope to see you there.
Randy Freides

***********************************
YOUR VIEW
Last week, we asked you if you were attending either VMX or WVC conferences this winter. 23% said you would be at VMX, 14% will be at WVC, and 18% will attend both. 46% said neither. For those who are going, we hope to see you there!

This week
Do you believe that animal health companies are investing adequately in livestock R&D?

en_USEnglish (United States)